Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-NK Cell Injection in Advanced Ovarian Cancer with Massive Ascites
NCT07435701Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jan 2026
- Primary completion
- Jan 2026
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of SK-NK cell injection in ovarian cancer, malignant ascites, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jan 2026; status: recruiting.
02
Drugs
SK-NK cell injection
03
Conditions
ovarian cancermalignant ascites
Beyond the preview
Go deeper on NCT07435701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435701.